Profiling of the human monocytic cell secretome by quantitative label-free mass spectrometry identifies stimulus-specific cytokines and proinflammatory proteins

Proteomics

Volumn 12, Issue 18, 2012, Pages 2833-2842

  Groessl, M ^a   Luksch, H ^b   Rosen Wolff A ^b   Shevchenko, A ^a   Gentzel, M ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Cell biology; Cytokines; Immune response; Protein marker discovery; Quantitative proteomics; Secretome profiling

Indexed keywords

CYTOKINE; GELATINASE A; GLUTATHIONE TRANSFERASE P1; INTERLEUKIN 1BETA; INTERLEUKIN 6 RECEPTOR ALPHA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PENTRAXIN 3; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1B; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR MIMICRY; MONOCYTE; PRIORITY JOURNAL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; TANDEM MASS SPECTROMETRY;

CELL LINE; CYTOKINES; HUMANS; IMMUNITY, CELLULAR; MASS SPECTROMETRY; MONOCYTES; PROTEOME; PROTEOMICS;

EID: 84866175781     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201200108     Document Type: Article

References (35)

1. Pavlou, M. P., Diamandis, E. P., The cancer cell secretome: a good source for discovering biomarkers? J. Proteomics 2010, 73, 1896-1906.
2. Hathout, Y., Approaches to the study of the cell secretome. Expert Rev. Proteomics 2007, 4, 239-248.
3. Makridakis, M., Vlahou, A., Secretome proteomics for discovery of cancer biomarkers. J. Proteomics 2010, 73, 2291-2305.
4. Skalnikova, H., Motlik, J., Gadher, S. J., Kovarova, H., Mapping of the secretome of primary isolates of mammalian cells, stem cells and derived cell lines. Proteomics 2011, 11, 691-708.
5. Kopf, M., Bachmann, M. F., Marsland, B. J., Averting inflammation by targeting the cytokine environment. Nat. Rev. Drug Discov. 2010, 9, 703-718.
6. Clarke, T. B., Weiser, J. N., Intracellular sensors of extracellular bacteria. Immunol. Rev. 2011, 243, 9-25.
7. Nunez, G., Intracellular sensors of microbes and danger. Immunol. Rev. 2011, 243, 5-8.
8. van de Veerdonk, F. L., Netea, M. G., Dinarello, C. A., Joosten, L. A., Inflammasome activation and IL-1beta and IL-18 processing during infection. Trends Immunol. 2011, 32, 110-116.
9. Martinon, F., Mayor, A., Tschopp, J., The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27, 229-265.
10. Horvath, G. L., Schrum, J. E., De Nardo, C. M., Latz, E., Intracellular sensing of microbes and danger signals by the inflammasomes. Immunol. Rev. 2011, 243, 119-135.
11. Nickel, W., The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes. Eur. J. Biochem. 2003, 270, 2109-2119.
12. Nickel, W., Seedorf, M., Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu. Rev. Cell Dev. Biol. 2008, 24, 287-308.
13. Davidson, A., Diamond, B., Autoimmune diseases. New Engl. J. Med. 2001, 345, 340-350.
14. Keller, M., Ruegg, A., Werner, S., Beer, H. D., Active caspase-1 is a regulator of unconventional protein secretion. Cell 2008, 132, 818-831.
15. Schroder, K., Tschopp, J., The inflammasomes. Cell 2010, 140, 821-832.
16. Grivennikov, S. I., Greten, F. R., Karin, M., Immunity, inflammation, and cancer. Cell 2010, 140, 883-899.
17. Mallick, P., Kuster, B., Proteomics: a pragmatic perspective. Nat. Biotechnol. 2010, 28, 695-709.
18. Ong, S. E., Mann, M., Mass spectrometry-based proteomics turns quantitative. Nat. Chem. Biol. 2005, 1, 252-262.
19. Wilm, M., Quantitative proteomics in biological research. Proteomics 2009, 9, 4590-4605.
20. Neilson, K. A., Ali, N. A., Muralidharan, S., Mirzaei, M. et al., Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011, 11, 535-553.
21. Wright, C. A., Howles, S., Trudgian, D. C., Kessler, B. M. et al., Label-free quantitative proteomics reveals differentially regulated proteins influencing urolithiasis. Mol. Cell Proteomics 2011, 10, M110 005686.
22. Negishi, A., Ono, M., Handa, Y., Kato, H. et al., Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry. Cancer Sci. 2009, 100, 514-519.
23. Deutsch, E. W., Mendoza, L., Shteynberg, D., Farrah, T. et al., A guided tour of the Trans-Proteomic Pipeline. Proteomics 2010, 10, 1150-1159.
24. Khan, Z., Bloom, J. S., Garcia, B. A., Singh, M. et al., Protein quantification across hundreds of experimental conditions. Proc. Natl. Acad. Sci. USA 2009, 106, 15544-15548.
25. Callister, S. J., Barry, R. C., Adkins, J. N., Johnson, E. T. et al., Normalization approaches for removing systematic biases associated with mass spectrometry and label-free proteomics. J. Proteome Res. 2006, 5, 277-286.
26. Polpitiya, A. D., Qian, W. J., Jaitly, N., Petyuk, V. A. et al., DAnTE: a statistical tool for quantitative analysis of -omics data. Bioinformatics 2008, 24, 1556-1558.
27. Bendtsen, J. D., Jensen, L. J., Blom, N., Von Heijne, G. et al., Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng. Des. Sel. 2004, 17, 349-356.
28. Carbon, S., Ireland, A., Mungall, C. J., Shu, S. et al., AmiGO: online access to ontology and annotation data. Bioinformatics 2009, 25, 288-289.
29. Esumi, N., Budarf, M., Ciccarelli, L., Sellinger, B. et al., Conserved gene structure and genomic linkage for D-dopachrome tautomerase (DDT) and MIF. Mamm. Genome 1998, 9, 753-757.
30. Colobran, R., Pedrosa, E., Carretero-Iglesia, L., Juan, M., Copy number variation in chemokine superfamily: the complex scene of CCL3L-CCL4L genes in health and disease. Clin. Exp. Immunol. 2010, 162, 41-52.
31. Mantovani, A., Garlanda, C., Bottazzi, B., Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 2003, 21(Suppl 2), S43-47.
32. Laskin, D. L., Sunil, V. R., Gardner, C. R., Laskin, J. D., Macrophages and tissue injury: agents of defense or destruction? Annu. Rev. Pharmacol. Toxicol. 2011, 51, 267-288.
33. Marks, S. D., Tullus, K., Autoantibodies in systemic lupus erythematosus. Pediatr. Nephrol. 2011, doi:10.1007/s00467-011-2078-4.
34. Meilof, J. F., Veldhoven, C. H., Swaak, A. J., Smeenk, R. J., Production of anti-Ro/SS-A and anti-La/SS-B autoantibodies is closely coordinated in systemic lupus erythematosus and independent of anti-dsDNA production. J. Autoimmun. 1997, 10, 67-75.
35. Luo, L., Wang, Y., Feng, Q., Zhang, H. et al., Recombinant protein gluthatione S-transferase attenuates inflammation in mice. Mol. Immun. 2009, 46, 848-857.